OR WAIT null SECS
© 2022 MJH Life Sciences and BioPharm International. All rights reserved.
© 2022 MJH Life Sciences™ and BioPharm International. All rights reserved.
April 01, 2022
Taking key considerations into account along the cell therapy supply chain can set cell therapy developers up for success.
Symbiosis announced the successful completion of UK Research and Innovation project to enhance the manufacturing supply chain for ATMPs within the UK.
March 18, 2022
New report released by USP offers a look into API supply-chain vulnerabilities.
March 15, 2022
Disruptions in the bio/pharmaceutical supply chain can have serious impacts on the quality and availability of life-saving medicines.
Interoperability by 2023 depends on data standardization and systems compatibility between trading partners.
March 11, 2022
Biotech companies and medical product manufacturers have condemned the invasion of Ukraine, while also looking to maintain supplies of essential medicines.
February 16, 2022
Thermo Fisher Scientific's solution for cell and gene therapies involves a combination of cold chain logistics, serialization compliance, and distribution
February 01, 2022
Lighthouse manufacturing techniques utilize technology and automation to streamline production.
January 01, 2022
New and emerging biotherapeutic molecules drive the need for innovative solutions to meet cold-chain requirements.
December 03, 2021
Moderna’s agreement with the UK government includes 29 million COVID-19 vaccine doses for delivery in 2022 and 31 million doses for delivery in 2023.